ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced the appointment of Jeff Fried to its Advisory Board. LENSai is one of the most…
DeciBio Consulting, LLC, a precision medicine-focused strategic consulting and market intelligence firm, has promoted Carl Schoellhammer, Ph.D., to Partner. Carl leads the firm’s advanced therapies practice and serves as Managing Director of the DeciBio BroadOak BioTools Venture Fund, a joint…
CareDx Announces Draft LCD Supporting Coverage for Transplant Rejection Surveillance Testing The Transplant Company – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – announced…
Biocytogen Holdings, a global biotechnology company driving drug discovery with innovative technologies, today announced it has entered into a global licensing agreement for antibody molecules with BeiGene, a global innovator in oncology treatment. BeiGene has previously obtained the authorization to…
Wedgewood is excited to announce the expansion and evolution of its Veterinary Advisory Committee to reflect the company’s continued growth and leadership in the veterinary community. As part of this transformation, the company welcomes new members to both the Strategic…
Nanochon announces Health Canada approval for first human study Nanochon, a Washington, DC, and Baltimore, MD-based orthopedic device biotechnology company developing implants to treat knee cartilage defects, is pleased to announce that it has been granted Health Canada approval for…
Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, today issued the following statement: Shortly after 2:30 p.m. ET today, Sarepta received an informal request from the U.S. Food and Drug Administration (FDA) to voluntarily halt shipment of…
Minnesota Health Market Review 2025 Reveals Sharp Declines in HMO Profitability and Medicaid Enrollment It has released Part 1 of the “Minnesota Health Market Review 2025”, marking the 36th edition of this comprehensive report series first launched in 1990. The…
The Texas Health Market Review 2025, the 17th report analyzing this dynamic market is now available. It contains 50 pages of data tables, trend graphics and narrative about the health insurers and hospital systems in the state. It describes the…
As cyber threats grow more frequent and sophisticated, rural hospitals and clinics face challenges on all fronts—tight budgets, limited staff, inadequate training, complex technology, and unsupportive vendors. Many are left trying to manage security tools without the IT resources to support…
Next-Generation NeoCast™ Liquid Embolic Offers Pain-Free Treatment and Rapid Healing for Chronic Subdural Hematoma Arsenal Medical, a clinical-stage company developing innovative biomaterials-based devices, today announced late-breaking data from the EMBO-02 clinical study for NeoCast™, a next-generation, shear-responsive liquid embolic treatment.…
Paige, a leader in next-generation AI technology, today announced the release of PRISM2, its most advanced slide-level foundation model to date. PRISM2 is designed to advance large language models (LLM) by enabling them to understand pathology images, connecting visual patterns with…